Literature DB >> 9521284

Sarcolemmal defect and subsarcolemmal lesion in a patient with gamma-sarcoglycan deficiency.

M Li1, D W Dickson, A J Spiro.   

Abstract

We report a case of gamma-sarcoglycanopathy with sarcolemmal defects and subsarcolemmal lesions indistinguishable from those in Duchenne muscular dystrophy. Both disorders share certain ultrastructure features that suggest a common pathogenesis related to primary deficiency of transmembrane glycoproteins (e.g., sarcoglycans) or deficiency in dystrophin, which produces a secondary deficiency in sarcoglycans. The lack of transmembrane glycoproteins may contribute to membrane lesions and associated muscle fiber degeneration and necrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521284     DOI: 10.1212/wnl.50.3.807

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  1 in total

1.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.